Histologic characteristics and KIT staining patterns of equine cutaneous mast cell tumors.
Authors: Clarke L, Simon A, Ehrhart E J, Mulick J, Charles B, Powers B, Duncan C
Journal: Veterinary pathology
Summary
# Editorial Summary: Equine Cutaneous Mast Cell Tumors Although mast cell tumors rarely behave aggressively in horses despite occasional clinical concerns, their true prognostic indicators remain poorly understood. Clarke and colleagues examined histologic characteristics and KIT immunostaining patterns in 72 equine cutaneous mast cell tumours, applying grading criteria and staining protocols adapted from canine oncology to determine whether either parameter predicted clinical outcomes. The vast majority of tumours (96%) were well-differentiated with low mitotic rates, whilst aberrant KIT expression—an adverse prognostic marker in dogs—appeared in only 12% of cases; notably, no tumours demonstrated malignant behaviour, and associated systemic disease was rare. Neither histologic grade nor KIT staining pattern correlated with poor clinical outcomes in this cohort, suggesting that assessment tools validated in canine cutaneous mast cell tumours may not reliably predict behaviour in equine patients. For practitioners managing these lesions, the research indicates a generally favourable prognosis regardless of histopathologic findings, though the marked overrepresentation of Arabians warrants further investigation into breed-specific predisposition and whether genetic factors influence tumour biology in this population.
Read the full abstract on PubMed
Practical Takeaways
- •Equine cutaneous mast cell tumors are predominantly benign with excellent prognosis; histopathology and KIT staining do not reliably predict aggressive behavior in horses as they may in dogs
- •Arabian horses may have higher predisposition to mast cell tumors and should be monitored for cutaneous masses
- •Standard grading schemes developed for canine mast cell tumors have limited prognostic value in horses and should not be used to guide treatment decisions
Key Findings
- •96% of equine cutaneous mast cell tumors were well-differentiated with low mitotic rates
- •Only 12% of tumors showed aberrant KIT staining patterns, in contrast to canine tumors
- •Arabian horses were overrepresented in the study population relative to reference data
- •Neither KIT staining pattern nor histologic features were associated with poor clinical outcome or malignant behavior